Cerus Corporation (CERS)
$2.69-4.27%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $539M
- Avg volume
- 2.8M
- Beta
- 1.77
- P/E (TTM)
- -74.31
- Short % float
- 7.89%
- Days to cover
- 5.7
- SI change
- +9.3%
- 1W
- -9.43%
- 1M
- -8.19%
- 3M
- -0.74%
- YTD
- +36.55%
- vs SPY 1W
- -8.24%
- vs SPY 1M
- -11.51%
- vs SPY 3M
- -3.13%
- vs SPY YTD
- +24.79%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- IMRNBUYImmuron LimitedRECOVERYQ 4$1.12+0.00%
- QNCXBUYQuince Therapeutics, Inc.RECOVERYQ -11$33.48-1.33%
- FBLGBUYFibroBiologics, Inc. Common StockRECOVERYQ -32$1.35-6.25%
- IMCRBUYImmunocore Holdings plcRECOVERYQ 5$36.61-0.73%
- STROSELLSutro Biopharma, Inc.CRISISQ -6$20.49-2.61%
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- ENVBSELLEnveric Biosciences, Inc.CRISISQ -8$1.41-1.40%
- WHWKBUYWhitehawk Therapeutics IncRECOVERYQ -12$4.88+3.17%
- THTXBUYTheratechnologies Inc.BULLQ 10$3.39+0.00%
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
- APUSSELLApimeds Pharmaceuticals US, IncCRISISQ -26$4.75-1.86%
- SCNIBUYScinai Immunotherapeutics Ltd.RECOVERYQ -3$3.13-2.80%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 15
- VALUE
- 4
- GROWTH
- 41
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-6.2%
REV YoY-
ROE-10.3%
EPS YoY-
ROA-3.3%
GROSS52
OP-1
NET-3
[VALUATION]
P/E TTM-74.31
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B7.70
P/FCF-
EV/EBITDA206.64
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E109.68
ALTMAN Z-
CURR RATIO1.83
ND/EBITDA-
BETA1.77
